Pascal Touchon is CEO & President at Atara Biotherapeutics, Inc. (ATRA). They have made 21 open-market trades across 1 company since 2020, most recently 2025-06-10.
CIK 0001780060
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 21 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ATRA | 77,955 | $658K |
Shares reported on the most recent Form 4, priced at the 2025-06-12 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ATRA | SELL | 2024-08-16 | 2024-08-20 | $6.63 | $20K | +4.8% | +9.4% | +56.3% |
| ATRA | SELL | 2024-05-16 | 2024-05-20 | $0.62 | $101K | -19.9% | -49.1% | -58.9% |
| ATRA | SELL | 2024-03-04 | 2024-03-06 | $0.72 | $18K | -17.3% | +7.5% | -21.1% |
| ATRA | SELL | 2023-11-16 | 2023-11-20 | $0.39 | $8K | +17.7% | +0.6% | +52.7% |
| ATRA | SELL | 2023-08-16 | 2023-08-18 | $1.65 | $51K | -2.7% | +4.0% | -68.0% |
| ATRA | SELL | 2023-06-27 | 2023-06-29 | $1.66 | $24K | +25.1% | +32.3% | -9.0% |
| ATRA | SELL | 2023-05-16 | 2023-05-18 | $2.04 | $121K | -26.4% | -8.2% | -18.8% |
| ATRA | SELL | 2023-03-02 | 2023-03-06 | $3.63 | $114K | -9.6% | -18.7% | -54.4% |
| ATRA | SELL | 2022-11-16 | 2022-11-18 | $4.49 | $140K | +4.3% | -19.0% | +2.8% |
| ATRA | SELL | 2022-08-16 | 2022-08-18 | $5.04 | $149K | -13.7% | -17.0% | -0.4% |
| ATRA | SELL | 2022-06-27 | 2022-06-29 | $7.20 | $102K | +16.7% | -59.2% | -55.1% |
| ATRA | SELL | 2022-05-17 | 2022-05-19 | $5.32 | $148K | -6.2% | +25.4% | -8.3% |
| ATRA | SELL | 2022-03-01 | 2022-03-03 | $9.86 | $174K | -9.9% | +4.1% | -48.9% |
| ATRA | SELL | 2021-11-16 | 2021-11-18 | $17.12 | $288K | -1.8% | -11.2% | -16.6% |
| ATRA | SELL | 2021-08-17 | 2021-08-19 | $12.53 | $206K | +26.1% | +36.7% | +49.8% |
| ATRA | SELL | 2021-06-25 | 2021-06-29 | $16.32 | $463K | -9.7% | -15.7% | +12.9% |
| ATRA | SELL | 2021-05-18 | 2021-05-20 | $14.55 | $242K | -4.5% | +8.1% | -13.6% |
| ATRA | SELL | 2021-03-02 | 2021-03-04 | $16.74 | $164K | +4.5% | -7.2% | -12.4% |
| ATRA | SELL | 2020-11-17 | 2020-11-18 | $19.77 | $186K | +12.6% | +4.1% | -10.3% |
| ATRA | SELL | 2020-08-18 | 2020-08-20 | $12.09 | $116K | -2.0% | +12.3% | +57.8% |
| ATRA | SELL | 2020-06-25 | 2020-06-26 | $12.92 | $314K | +14.5% | +4.0% | -6.1% |
| ATRA | SELL · 10b5-1 | 2020-05-18 | 2020-05-20 | $11.22 | $36K | -25.8% | -25.1% | -15.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.